FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease

March 25 (Reuters) - U.S. Food and Drug Administration staff

members said on Friday Acadia Pharmaceuticals Inc's

drug to treat psychosis associated with Parkinson's disease was

effective enough to...

Read more